Merck Sharp & Dohme B.V.

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 3
Amount won alone: €5,026,718 excl. VAT
Period: 14 August 2026 – 21 September 2026

Its main clients

NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE · 2 contracts
Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria · 1 contract

Where and what

Supplies · 3

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
31 December 2027 re-tender around July 2027	Nakup cepiva pcv 21 in cepiva proti rsv NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE framework agreement	Merck Sharp & Dohme B.V. 1 bid received	€416,600
14 July 2028 re-tender around January 2028	Nakup dolgo delujočega monoklonskega protitelesa proti rsv NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE framework agreement	Merck Sharp & Dohme B.V. 2 bids received	€4,374,250

Contracts won

Date	Contract	Buyer	Amount
21/09/2026	Nakup cepiva pcv 21 in cepiva proti rsv	NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE	€416,600
21/09/2026	Nakup dolgo delujočega monoklonskega protitelesa proti rsv	NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE	€4,374,250
14/08/2026	Suministro de medicamentos exclusivos de la empresa MERCK-SHARP & DOHME, S.A. para la Gerencia de Atención Sanitaria de Melilla.	Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria	€235,868

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.